Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TREACE MEDICAL CONCEPTS, INC.
Report date March 15, 2023 · Filed March 17, 2023
Section 16 reporting ended · disclosed 2023-03-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,914 |
Last balance in matching sequence
After 2023-03-15 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-03-15 · Exercise / conversion · Acquired 6,250 · Balance 37,164 F1: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2: Includes 25,650 RSUs. Row 2 · 2023-03-15 · Sale · Disposed 6,250 · Balance 30,914 F1: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes 25,650 RSUs. |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $7.03 · Expires 2031-02-02 | Direct | 176,375 |
Reported balance
After 2023-03-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-15 · Exercise / conversion · Disposed 6,250 · Balance 176,375 F4: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: Includes 25,650 RSUs.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 6,250 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,375 Underlying: Stock Option Right to Buy · 6,250 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 6,250 | $22.87 | $142,955.63 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,914 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 25,650 RSUs. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 6,250 | $7.03 | $43,925.00 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 25,650 RSUs. Read SEC document |
| March 10, 2023 Filed Mar 10, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option Right to Buy · Derivative | 46,750 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001209191-23-018043 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,750 Underlying: Stock Option Right to Buy · 46,750 shares Expires 2033-03-10 F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 10, 2023 Filed Mar 10, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 20,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018043 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,914 F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. F4 · balance_after: Includes 25,650 RSUs. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 411 | $24.41 | $10,032.51 |
DisclosureSEC source: 0001209191-23-018043 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,289 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 5,025 RSUs. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 1,875 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · derivative · entry 6 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,688 Underlying: Common stock · 1,875 shares Expires 2031-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 3,750 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · derivative · entry 5 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,625 Underlying: Common Stock · 3,750 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,875 | $25.00 | $46,875.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · nonDerivative · entry 4 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,875 | $17.00 | $31,875.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · nonDerivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 3,750 | $25.00 | $93,750.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 3,750 | $7.03 | $26,355.00 |
DisclosureSEC source: 0001209191-22-059532 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 6,250 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-057740 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,375 Underlying: Common Stock · 6,250 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 6,250 | $20.38 | $127,371.25 |
DisclosureSEC source: 0001209191-22-057740 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.3432 to $20.4338 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 6,250 | $7.03 | $43,925.00 |
DisclosureSEC source: 0001209191-22-057740 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| September 02, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 1,500 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · derivative · entry 6 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,625 Underlying: Common Stock · 1,500 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| September 02, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,500 | $20.04 | $30,060.00 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · nonDerivative · entry 4 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| September 02, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,500 | $7.02 | $10,531.20 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · nonDerivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 1,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · derivative · entry 5 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,125 Underlying: Common Stock · 1,000 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $19.50 | $19,502.00 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.1600 to $19.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $7.03 | $7,028.00 |
DisclosureSEC source: 0001209191-22-048607 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 17:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 1,500 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-046000 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,125 Underlying: Common Stock · 1,500 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 17:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,500 | $20.00 | $30,000.00 |
DisclosureSEC source: 0001209191-22-046000 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 17:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,500 | $7.03 | $10,542.00 |
DisclosureSEC source: 0001209191-22-046000 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 07:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option Right to Buy · Derivative | 1,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-22-044026 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,625 Underlying: Common Stock · 1,000 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 07:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $16.89 | $16,890.40 |
DisclosureSEC source: 0001209191-22-044026 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.58 to $17.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 07:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $7.03 | $7,028.00 |
DisclosureSEC source: 0001209191-22-044026 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,700 RSUs. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:54 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001567619-22-013730 · doc1.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,625 Underlying: Common Stock · 1,000 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:54 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $15.00 | $15,000.00 |
DisclosureSEC source: 0001567619-22-013730 · doc1.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:54 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $7.03 | $7,028.00 |
DisclosureSEC source: 0001567619-22-013730 · doc1.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:12 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001567619-22-012339 · doc1.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,625 Underlying: Common Stock · 1,000 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:12 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $16.67 | $16,670.00 |
DisclosureSEC source: 0001567619-22-012339 · doc1.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:12 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $7.03 | $7,028.00 |
DisclosureSEC source: 0001567619-22-012339 · doc1.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 6,700 RSUs. Read SEC document |
| May 09, 2022 Filed May 11, 2022 18:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001567619-22-010102 · doc1.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,625 Underlying: Common Stock · 1,000 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025. Read SEC document |
| May 09, 2022 Filed May 11, 2022 18:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $15.96 | $15,960.00 |
DisclosureSEC source: 0001567619-22-010102 · doc1.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Represents 6,700 RSUs. Read SEC document |
| May 09, 2022 Filed May 11, 2022 18:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $7.03 | $7,028.00 |
DisclosureSEC source: 0001567619-22-010102 · doc1.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Represents 6,700 RSUs. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:27 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 51,600 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001567619-22-006734 · doc1.xml · derivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,600 Underlying: Common Stock · 51,600 shares Expires 2032-03-08 F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:27 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 6,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-006734 · doc1.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Represents 6,700 RSUs. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:04 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | PurchaseCommon | 4,000 | $17.00 | $68,000.00 |
DisclosureSEC source: 0000899243-21-017456 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:56 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 73,563 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017025 · doc4.xml · derivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,563 Underlying: Common Stock · 73,563 shares Expires 2031-04-22 F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.